EULAR 2026 Interview: Antoni Chan
Antoni Chan discusses the implementation of the RheumACaN program, which aims to improve the early diagnosis and referral of inflammatory arthritis. The program combines clinician education with pathway redesign to ensure faster patient access to disease-modifying antirheumatic drugs.
Why it matters
Improving diagnostic pathways for chronic conditions like inflammatory arthritis is critical for reducing long-term patient disability and healthcare costs.
Elaine Dennison University of Reading; Royal Berkshire NHS Foundation Trust, Reading, UK
The content is a professional interview focused on clinical outcomes and medical process improvement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in